J.C. Dumon

470 total citations
18 papers, 360 citations indexed

About

J.C. Dumon is a scholar working on Oncology, Orthopedics and Sports Medicine and Molecular Biology. According to data from OpenAlex, J.C. Dumon has authored 18 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Orthopedics and Sports Medicine and 6 papers in Molecular Biology. Recurrent topics in J.C. Dumon's work include Bone health and treatments (15 papers), Bone health and osteoporosis research (5 papers) and Parathyroid Disorders and Treatments (3 papers). J.C. Dumon is often cited by papers focused on Bone health and treatments (15 papers), Bone health and osteoporosis research (5 papers) and Parathyroid Disorders and Treatments (3 papers). J.C. Dumon collaborates with scholars based in Belgium, Switzerland and France. J.C. Dumon's co-authors include J.J. Body, Jean‐Jacques Body, J.J. Body, Évelyne Gineyts, Fabrice Journé, Guy Leclercq, Naı̈ma Kheddoumi, John Fox, J. Ford and Marc Schrooyen and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and British Journal of Cancer.

In The Last Decade

J.C. Dumon

18 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.C. Dumon Belgium 12 273 135 95 80 72 18 360
Peter Smolens United States 5 196 0.7× 47 0.3× 17 0.2× 159 2.0× 41 0.6× 5 314
Todor Dentchev United States 8 365 1.3× 51 0.4× 29 0.3× 37 0.5× 76 1.1× 13 441
ALEXANDRA DIMICH United States 10 75 0.3× 22 0.2× 56 0.6× 50 0.6× 61 0.8× 16 335
Jochen Ittner Germany 6 109 0.4× 116 0.9× 10 0.1× 292 3.6× 18 0.3× 7 577
Andrea De Censi Italy 10 186 0.7× 54 0.4× 12 0.1× 150 1.9× 34 0.5× 39 349
Takumi Endo Japan 11 97 0.4× 16 0.1× 43 0.5× 77 1.0× 133 1.8× 38 347
Kazutoshi Mizunashi Japan 9 64 0.2× 50 0.4× 5 0.1× 81 1.0× 55 0.8× 24 390
Takuo Fujita Japan 11 170 0.6× 15 0.1× 5 0.1× 135 1.7× 49 0.7× 16 351
Betty S. Roof United States 12 88 0.3× 21 0.2× 7 0.1× 60 0.8× 61 0.8× 20 390
D.E.M. Lawson Canada 6 64 0.2× 25 0.2× 17 0.2× 74 0.9× 218 3.0× 10 382

Countries citing papers authored by J.C. Dumon

Since Specialization
Citations

This map shows the geographic impact of J.C. Dumon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.C. Dumon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.C. Dumon more than expected).

Fields of papers citing papers by J.C. Dumon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.C. Dumon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.C. Dumon. The network helps show where J.C. Dumon may publish in the future.

Co-authorship network of co-authors of J.C. Dumon

This figure shows the co-authorship network connecting the top 25 collaborators of J.C. Dumon. A scholar is included among the top collaborators of J.C. Dumon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.C. Dumon. J.C. Dumon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Journé, Fabrice, Carole Chaboteaux, J.C. Dumon, et al.. (2004). Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells. British Journal of Cancer. 91(9). 1703–1710. 20 indexed citations
2.
Journé, Fabrice, J.C. Dumon, Naı̈ma Kheddoumi, et al.. (2004). Extracellular calcium downregulates estrogen receptor alpha and increases its transcriptional activity through calcium-sensing receptor in breast cancer cells. Bone. 35(2). 479–488. 43 indexed citations
3.
Body, J.J., Isabelle Mancini, & J.C. Dumon. (2004). Intensive intravenous ibandronate treatment significantly relieves opioid-resistant bone pain and improves quality of life in patients with skeletal metastases. European Journal of Cancer Supplements. 2(3). 133–133. 1 indexed citations
4.
Dumon, J.C., Naı̈ma Kheddoumi, Laurence Lagneaux, Fabrice Journé, & J.J. Body. (2004). Effects of bisphosphonates and insulin-like growth factor-1 (IGF-1) on prostate cancer cells in vitro. Journal of Clinical Oncology. 22(14_suppl). 4758–4758. 4 indexed citations
5.
Dumon, J.C., et al.. (2001). Hypercalcaemia of melanoma: incidence, pathogenesis and therapy with bisphosphonates. Melanoma Research. 11(5). 477–482. 11 indexed citations
6.
Body, Jean‐Jacques, J.C. Dumon, Didier Blocklet, & Claude Darte. (1997). The bone isoenzyme of alkaline phosphatase in hypercalcaemic cancer patients. European Journal of Cancer. 33(10). 1578–1582. 2 indexed citations
7.
Body, J.J., et al.. (1997). Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy. British Journal of Cancer. 75(3). 408–412. 43 indexed citations
8.
Schrooyen, Marc, et al.. (1997). Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria. Clinical Rheumatology. 16(1). 93–95. 15 indexed citations
9.
Dumon, J.C., et al.. (1996). Technical and clinical validation of a new immunoradiometric assay for human osteocalcin. European Journal of Endocrinology. 135(2). 231–237. 20 indexed citations
10.
Body, Jean‐Jacques, et al.. (1996). A dose response study of intravenous pamidronate in postmenopausal osteoporosis. Osteoporosis International. 6(S1). 247–247. 1 indexed citations
11.
Body, Jean‐Jacques, J.C. Dumon, Martine Piccart, & J. Ford. (1995). Intravenous pamidronate in patients with tumor-induced osteolysis: A biochemical dose-response study. Journal of Bone and Mineral Research. 10(8). 1191–1196. 17 indexed citations
12.
Body, J.J. & J.C. Dumon. (1994). Treatment of tumour-induced hypercalcaemia with the bisphosphonate pamidronate: Dose-response relationship and influence of tumour type. Annals of Oncology. 5(4). 359–363. 60 indexed citations
13.
Body, J.J., Jean‐Pierre Chanoine, J.C. Dumon, & François Delange. (1993). Circulating calcitonin levels in healthy children and subjects with congenital hypothyroidism from birth to adolescence.. The Journal of Clinical Endocrinology & Metabolism. 77(2). 565–567. 9 indexed citations
14.
Body, Jean‐Jacques, et al.. (1993). Circulating PTHrP concentrations in tumor-induced hypercalcemia: Influence on the response to bisphosphonate and changes after therapy. Journal of Bone and Mineral Research. 8(6). 701–706. 33 indexed citations
15.
Dumon, J.C., et al.. (1992). Nasal human calcitonin for tumor-induced hypercalcemia. Calcified Tissue International. 51(1). 18–19. 17 indexed citations
16.
Body, J.J., et al.. (1992). Recovery of parathyroid hormone secretion during correction of tumor-associated hypercalcemia.. The Journal of Clinical Endocrinology & Metabolism. 74(6). 1385–1388. 11 indexed citations
17.
Dumon, J.C., et al.. (1991). Efficacy and safety of the bisphosphonate tiludronate for the treatment of tumor-associated hypercalcemia. Bone and Mineral. 15(3). 257–266. 46 indexed citations
18.
Dumon, J.C., et al.. (1971). Concordance for amyotrophic lateral sclerosis in a pair of dizygous twins of consanguineous parents.. Journal of Medical Genetics. 8(1). 113–116. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Smolens Breakdown of academic impact, for papers by Todor Dentchev Breakdown of academic impact, for papers by ALEXANDRA DIMICH Breakdown of academic impact, for papers by Jochen Ittner Breakdown of academic impact, for papers by Andrea De Censi Breakdown of academic impact, for papers by Takumi Endo Breakdown of academic impact, for papers by Kazutoshi Mizunashi Breakdown of academic impact, for papers by Takuo Fujita Breakdown of academic impact, for papers by Betty S. Roof Breakdown of academic impact, for papers by D.E.M. Lawson
Rankless by CCL
2026